國家衛生研究院 NHRI:Item 3990099045/8204
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 913263      線上人數 : 1142
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8204


    題名: CSF2 overexpression as a poor prognostic factor in patients with urothelial carcinoma of the upper urinary tract and urinary bladder
    作者: Lee, YY;Wu, WJ;Huang, CN;Li, CC;Ke, HL;Li, WM;Yeh, HC;Li, CF;Lin, HH;Yeh, BW;Hwang, SJ;Liang, PI
    貢獻者: National Institute of Cancer Research
    摘要: Background Through data mining of a published transcriptomic database of urothelial carcinomas of the urinary bladder (GSE32894), colony stimulating factor 2 (CSF2) was identified as the most significant gene showing stepwise upregulation related to positive regulation of tyrosine phosphorylation of STAT5 (GO:0042523). We therefore analysed CSF2 transcript and protein expression and their association with clinicopathological factors and survival in our well-characterised cohort of urothelial carcinomas. Methods Laser capture microdissection coupled with real-time qRT-PCR was used to detect CSF2 transcript level in 24 urothelial carcinomas of the urinary bladder and six non-tumour urothelium samples. Immunohistochemistry evaluated by using H-score was used to determine CSF2 protein expression in 296 urothelial carcinomas of the urinary bladder and 340 urothelial carcinomas of the upper urinary tract. Protein expression was correlated with clinicopathological features and disease-specific survival (DSS) and metastasis-free survival (MeFS). Findings CSF2 transcripts were detected exclusively in tumour lesions (p = 0.010) with stepwise upregulation. CSF2 protein overexpression was significantly associated with advanced pT status (urothelial carcinomas of the upper urinary tract, p = 0.011; urothelial carcinomas of the urinary bladder, p < 0.001), and perineural invasion (urothelial carcinomas of the upper urinary tract, p = 0.002; urothelial carcinomas of the urinary bladder, p = 0.001) in both groups of urothelial carcinoma. CSF2 overexpression not only predicted worse DSS (urothelial carcinomas of the upper urinary tract, p = 0.0001; urothelial carcinomas of the urinary bladder, p < 0.0001) and MeFS (urothelial carcinomas of the upper urinary tract, p = 0.0001; urothelial carcinomas of the urinary bladder, p = 0.0002) at univariate analysis, but also inferior DSS (urothelial carcinomas of the upper urinary tract, p = 0.015; urothelial carcinomas of the urinary bladder, p = 0.004) and MeFS (urothelial carcinomas of the upper urinary tract, p = 0.008; urothelial carcinomas of the urinary bladder, p = 0.027) in multivariate analysis. Interpretation CSF2 overexpression is associated with advanced clinical features for both patients with urothelial carcinomas of the upper urinary tract and urothelial carcinomas of the urinary bladder, suggesting it may serve as a potential prognostic and a novel therapeutic target of urothelial carcinoma.
    日期: 2014-05
    關聯: European Journal of Cancer. 2014 May;50(Suppl. 4):e35-e36.
    Link to: http://dx.doi.org/10.1016/j.ejca.2014.03.138
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0959-8049&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000351589200099
    顯示於類別:[其他] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    SDO0959804914004109.pdf46KbAdobe PDF488檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋